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Mumijo is a traditional medicine used in Central Asia thousands of years. Its beneficial effect is exerted 
on metabolic processes and on the human immune system. It is also used as an antiseptic agent. The 
in vitro antibacterial activity of a mumijo preparation was investigated with agar diffusion technique 
against 25 Gram-positive and 6 Gram-negative bacterial isolates representing 13 different genera. Effect 
of different media and pH on the antibacterial action was also studied. Different concentrations of 
mumijo exerted bactericid and/or bacteriostatic effect against 3 Gram-negative (Acidovorax delafieldii, 
Serratia marcescens, Variovorax paradoxus) and 15 Gram-positive bacterial isolates (Agrococcus 
jenensis, Arthrobacter globiformis, Bacillus benzoevorans, Bacillus cereus var. mycoides, Bacillus 
megaterium, Bacillus subtilis, Enterococcus faecalis, Staphylococcus aureus) on the complete media. 
The maximum inhibitory potential of mumijo was observed at neutral pH (pH=7.4). Antibacterial effect of 
mumijo was not observed when minimal media were used for cultivation. The experimental data 
revealed that mumijo has remarkable growth inhibition effect against Gram-positive bacteria on 
complete medium at neutral pH. 
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INTRODUCTION 
 
Mumijo has been used as a traditional medicine in 
Central Asia for thousands of years. This material is the 
fossil deposits of snow petrel (Pagodroma nivea) 
stomach and is located in the high mountainous regions 
(2000-5000 m) of Central Asia (Aiello et al., 2008). The 
beneficial effects of mumijo are exerted on metabolic 
processes and on the human immune system and it also 
has antiseptic activity (Garedew et al., 2004; Aiello et al., 
2008). Garedew et al. (2004) demonstrated with micro-
calorimetric measurements that mumijo is a complex 
mixture of effective pharmacological substances that acts 
as a natural bacteriostatic agent against two Gram-
positive   bacteria,   Bacillus   brevis   and   Bacillus 
subtilis (Garedew et al., 2004). They mentioned in their 
study that mumijo is more effective against Gram-positive 
 
 
 
*Corresponding author. E-mail: galgoczi@gmail.com. Tel: +36 
62 544 005. Fax: +36 62 544 823. 
than Gram-negative bacterial isolates, but it and a 
comprehensive study of this feature has not been 
published so far. Therefore, in the present study we 
investigated the in vitro antibacterial activity of a mumijo 
preparation from Mongolia on different media and on 
different pH against 6 Gram-negative and 25 Gram 
positive bacterial isolates representing 13 different 
genera. 
 
 
MATERIALS AND METHODS 
 
Strains and media 
 
Bacterial isolates (Table 1) were maintained on T1 medium (4 g/L 
beef extract, 4 g/L peptone, 10 g/L glucose, 1 g/L yeast extract, 20 
g/L agar) at 4°C. The antibacterial activity assays were performed 
in T1, LB (10 g/L tryptone, 2 g/L yeast extract, 10 g/L NaCl, 20 g/L 
agar), T3A/B (A: 2 g/L NaNO3 / B: 2 g/L (NH4)2SO4, 0,5 g/L 
MgSO4×7H2O, 0,5 g/L KCl, 0,5 g/L K2HPO4, 30 g/L sucrose, 10 
mg/L ZnSO4×7H2O, 10 mg/L  FeSO4×7H2O, 3  mg/L  CuSO4×7H2O,  
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Table 1. In vitro antibacterial effect of different dilutions of a Mongolian mumijo preparation on complete media in agar diffusion test after incubation at 30°C for 24 and 48 h. 
 
Species 
Diameter of inhibition zone (mm) 
T1 medium  LB medium 
24 h  48 h   24 h  48 h 
10× 50× 100×  10× 50×  100× 10× 50× 100×  10× 50× 100× 
Gram-negative isolates                
A. delafieldii (SZMC 6210) 33±2.5 13±2.3 0±0.0  26±2.5 0±0.0  0±0.0 16±0.6 0±0.0 0±0.0  13±3.2 0±0.0 0±0.0 
S. marcescens (SZMC 0567) 12±1.0 11±0.6 10±0.3  0±0.0 0±0.0  0±0.0 0±0.0 0±0.0 0±0.0  0±0.0 0±0.0 0±0.0 
V. paradoxus (SZMC 6203) 29±2.6 16±1.2 0±0.0  26±2.5 0±0.0  0±0.0 16±0.6 0±0.0 0±0.0  13±3.2 0±0.0 0±0.0 
                
Gram-positive isolates                
A. jenensis (SZMC 6202) 36±2.1 19±2.1 12±0.6  34±1.5 19±0.6  0±0.0 21±0.6 0±0.0 0±0.0  17±1.2 0±0.0 0±0.0 
A. globiformis (SZMC 6205) 18±0.6 0±0.0 0±0.0  0±0.0 0±0.0  0±0.0 0±0.0 0±0.0 0±0.0  0±0.0 0±0.0 0±0.0 
B. benzoevorans (SZMC 6219) 18±1.0 12±0.6 0±0.0  14±0.6 0±0.0  0±0.0 12±1.2 0±0.0 0±0.0  11±2.3 0±0.0 0±0.0 
B. cereus var. mycoides (SZMC 0042) 12±1.5 9±0.0 0±0.0  9±0.6 8±0.0  0±0.0 12±0.6 10±0.6 9±1.0  11±1.2 6±5.5 0±0.0 
B. megaterium (SZMC 0571) 12±0.5 9±0.5 0±0.0  10±0.6 6±5.5  0±0.0 12±0.0 4±0.0 0±0.0  12±0.0 0±0.0 0±0.0 
B. subtilis (SZMC 14624) 16±1.5 15±1.2 11±0.6  16±1.2 15±1.2  11±0.6 16±0.6 14±1.5 11±0.6  15±1.0 12±0.0 0±0.0 
B. subtilis (SZMC 0209) 19±3.6 0±0.0 0±0.0  15±0.5 0±0.0  0±0.0 24±1.5 16±1.5 0±0.0  18±1.5 13±1.0 0±0.0 
B. subtilis (SZMC 6334) 13±0.6 0±0.0 0±0.0  13±0.6 0±0.0  0±0.0 9±0.6 0±0.0 0±0.0  9±0.6 0±0.0 0±0.0 
B.subtilis (SZMC 6332) 11±0.6 0±0.0 0±0.0  11±0.6 0±0.0  0±0.0 0±0.0 0±0.0 0±0.0  0±0.0 0±0.0 0±0.0 
E. faecalis (SZMC 14617) 18±1.2 11±0.6 0±0.0  0±0.0 18±1.2  11±0.6 0±0.0 0±0.0 0±0.0  0±0.0 0±0.0 0±0.0 
E. faecalis (ATTC 2912) 13±0.6 0±0.0 0±0.0  0±0.0 0±0.0  0±0.0 13±0.6 0±0.0 0±0.0  0±0.0 0±0.0 0±0.0 
E. faecalis (SZMC 0227) 13±1.0 0±0.0 0±0.0  0±0.0 0±0.0  0±0.0 13±1.0 0±0.0 0±0.0  0±0.0 0±0.0 0±0.0 
S. aureus (SZMC 14529) 20±1.5 0±0.0 0±0.0  18±1.0 0±0.0  0±0.0 0±0.0 0±0.0 0±0.0  10±0.6 0±0.0 0±0.0 
S. aureus (SZMC 6271) 0±0.0 0±0.0 0±0.0  0±0.0 0±0.0  0±0.0 11±1.7 0±0.0 0±0.0  10±0.6 0±0.0 0±0.0 
S. aureus (SZMC 14619) 11±0.6 0±0.0 0±0.0  0±0.0 0±0.0  0±0.0 9±0.6 0±0.0 0±0.0  0±0.0 0±0.0 0±0.0 
 
Culture collection abbreviations: ATTC, American Type Culture Collection, USA; SzMC, Szeged Microbial Collection, University of Szeged, Hungary. The diameter of the hole was 8 mm in the agar 
diffusion test. 
 
 
 
20 g/L agar) and T4A/B (A: 5 g/L NaNO3 / B: 5 g/L 
(NH4)2SO4, 1 g/L KH2PO4, 0,5 g/L MgSO4×7H2O, 10 g/L 
glucose, 20 g/L agar, 1 ml Wickerham vitamin solution) 
medium. 
 
 
Preparation of mumijo 
 
Mumijo preparation was made by the Microbial  
Biosynthesis Laboratory, Institute of Biology, Mongolian 
Academy of Sciences (Ulaanbaatar, Mongolia). The 
mumijo (collected from high mountains around Ulanbataar) 
was ground and milled, the powder was soaked in distilled 
water in 1:2 ratio in room temperature for 24 h. This 
solution was filtered on cheese cloth then the clear solution 
was concentrated with Anhydro A/S drier (Denmark) at 
80°C inner and 65°C outer temperature. The dry matter 
content of the mumijo preparation was 50%. 
Antibacterial activity assay 
 
The effect of mumijo on the growth of bacterial isolates 
was examined in different culture media (LB, T1, T3A, T3B, 
T4A and T4B; pH=7.0) and at different pH. An agar 
diffusion technique was used to estimate the size of 
inhibition of bacterial growth by different concentrations of 
mumijo. Solid culture media (LB, T1, T3A, T3B, T4A and 
T4B; pH=7.0) were overlaid with 1 ml of  similar  broth  that  
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Figure 1. pH-dependence of the antimicrobial activity of 10-fold diluted mumijo 
preparation in TRIS/HCl buffer (pH=7.2-8.2) against B. subtilis (SZMC 14624) and E. 
faecalis (SZMC 14617). 
 
 
 
were inoculated with 106 bacterial cell/ml. After drying 100 µl 
aliquots of a serial mumijo dilution (10, 50, 100 and 200 fold dilution 
in sterile distilled water) were filled into wells. Sterile distilled water 
was used as negative control. 
The two most susceptible microorganisms (B. subtilis and E. 
faecalis) cultured on the most suitable medium (T1) were used in 
the investigation of pH-dependence of antibacterial effect. 
In the preliminary experiments, pH values set by 20% NaOH and 
30% HCl at pH=5, 6, 7, 8, 9 were used. Based on the results of 
these investigations, in further experiments mumijo was solved (10 
fold) in TRIS/HCl buffer (pH=7.2, 7.4, 7.6, 7.8, 8.0 and 8.2). In this 
case sterile buffers were used as negative controls. The diameters 
of the inhibition zones were measured after incubation at 30°C for 
24 and 48 h. All experiments were repeated three times. 
 
 
RESULTS 
 
Mongolian mumijo was ineffective on minimal media 
(T3A/B and T4A/B) but showed substantial antibacterial 
effect on complete media (T1 and LB). Growth of the 
most investigated Gram-positive bacteria (Agrococcus 
jenensis SZMC 6202; Arthrobacter globiformis SZMC 
6205; Bacillus benzoevorans SZMC 6219; Bacillus 
cereus var. mycoides SZMC 0042; Bacillus megaterium 
SZMC 0571; B. subtilis SZMC 14624, SZMC 0209, 
SZMC 6334,SZMC 6332; E. faecalis SZMC 14617, ATTC 
2912, SZMC 0227; Staphylococcus aureus SZMC 14529, 
SZMC 6271, SZMC 14619) was inhibited by mumijo, at 
the same time only three investigated Gram-negative 
bacteria (Acidovorax delafieldii SZMC 6210, Serratia 
marcescens SZMC 0567, Variovorax paradoxus SZMC 
6203) proved to be sensitive (Table 1). Mumijo was 
ineffective against the other Gram-negative (Escherichia 
coli SZMC 0582, Eubacter gergoviae SZMC 6222, 
Pseudomonas aeruginosa SZMC 0568) and Gram-
positive (Enterococcus hirae SZMC 14623, Micrococcus 
luteus SZMC 6207, SZMC 0197, S. aureus SZMC 0579, 
SZMC 14623, ATCC 25923, Staphylococcus epidermidis 
SZMC 14531, Streptococcus agalactiae SZMC 14533, 
Streptococcus pneumoniae ATTC 49619, Streptococcus 
pyogenes SZMC 14535) strains involved in this study. In 
our in vitro tests inhibition zones were clearly detectable 
in cases of the 10, 50 and 100 fold dilutions of mumijo 
preparation and antibacterial effect were not observed in 
case of the 200 fold dilution. In cases of some isolates 
the diameters of the inhibition zones disappeared after 
incubation of 48 h indicated that the mumijo acted 
bacteriostatically against them. These data are 
summarized in Table 1. 
The pH dependence of the antibacterial effect of 10-
fold diluted mumijo was investigated in T1 medium at 
different pHs (pH=5-9) against the two most susceptible 
bacterial isolates which are important in practical 
respects. B. subtilis is known as food poison causing 
bacterium (Apetroaie-Constantin et al., 2009). E. faecalis 
can cause serious life-threatening infections (e.g. 
endocarditis; bladder, prostate, epididymal, nervous 
system infections) in consequence of the wide distribution 
of multi-resistant strains all over the world (Sava et al., 
2010). The antibacterial effect of mumijo was observed 
only at pH=6 and 7 after 24 and 48 h of incubation at 
30°C in case of B. subtilis SZMC 14624 (diameters of the 
inhibition zones were 12±1.2 and 16±1.7 at pH=6  and  7, 
respectively) and E. faecalis SZMC 14617 (diameters of 
the inhibition zones were 13±1.0 and 19±1.0 at pH=6 and 
7, respectively). Based on these data mumijo was diluted 
(10 fold) in TRIS/HCl buffers (pH=7.2 to 8.2) to determine 
the optimal pH of mumijo dilution in respect of the 
antibacterial effect. This pH was at pH=7.4 in case of the 
both investigated bacteria (Figure 1). These data 
suggested that  the  antibacterially  active  compounds  of  
  
 
 
mumijo are effective at pH=6-8. 
 
 
DISCUSSION 
 
Mumijo is a widely and clinically used natural, human 
medicine in the oriental region of the world (e.g. Russia 
and China). Its beneficial effect on health recovery is 
demonstrated in patients with different infections, gastric 
and intestinal ulcers, fractures and after radiation 
(Garedew et al., 2004; Aiello et al., 2008). These features 
of this material are connected with its immune-stimulating 
and antiallergic activity (Aiello et al., 2008). The antitoxic 
and cholagogic properties of the dry mumijo extract are 
also revealed (Frolova et al., 1998). Spassow (1994) 
observed the nootropic activity of mumijo and Aiello et al. 
(2008) its strong neuroprotective effect in cortical neurons 
against apoptosis. The antibacterial activity of mumjo has 
not been intensively studied so far. 
Data about the antibacterial effect of mumijo in the 
literature were available only in case of two Bacillus 
isolates (Garedew et al., 2004). In our in vitro study the 
different concentration of a mumijo preparation showed 
remarkable antibacterial effect. Effectiveness against 
Gram-negative bacteria and the pH dependence of the 
antibacterial activity has not been revealed so far. In our 
in vitro study mumijo inhibited the growth of both type of 
bacteria, among them some potential human pathogens 
(e.g. B. subtilis, E. faecalis, S. aureus). This observation 
suggests the possible application of mumijo in treatment 
of bacterial infections. It is hypothesized that the 
differences between the antibacterial activity of mumijo in 
the complete and minimal medium might be based on the 
different uptake mechanism of the bacterial cells which 
are activated by different nutrients. The antibacterial 
compounds of mumijo might get into the cell in an uptake 
mechanism activated by only the complete media. 
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Conclusion 
 
Our study revealed that mumijo has an antibacterial 
effect. With further investigation of this complex mixture, 
mumijo would be promising agent in food and 
pharmaceutical industry in the near future. 
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